-
Thermo Fisher, Daiichi Sankyo to Co-Develop CDx
contractpharma
June 24, 2020
Agreement aims to identify HER2 gene mutations using Oncomine Dx Target Test for patients with Non-Small Cell Lung Cancer.
-
PharmAbcine Enters Partnership with Thermo Fisher
contractpharma
June 16, 2020
Will develop and manufacture Thermo Fisher’s immune checkpoint blockade, PMC-309 for Phase I.
-
Thermo Fisher, Agios Pharma to Co-develop Oncology CDx
contractpharma
June 10, 2020
To identify IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new sequencing solution.
-
Thermo Fisher Gets Expanded EUA for SARS‑CoV‑2 Test
contractpharma
May 14, 2020
This third expansion further increases the number of high-throughput PCR instruments that labs can use to run tests.
-
Thermo Fisher Launches SARS-CoV-2 GlobalAccess Sequencing Program
contractpharma
May 08, 2020
Provides 50 units of the Genexus System at a subsidized price to support global collaborative COVID-19 research.
-
FDA Issues EUA to Thermo Fisher
contractpharma
March 17, 2020
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Thermo Fisher Scientific’s diagnostic test that can be used immediately...
-
Thermo Fisher with Frontier Bio to develop novel HIV treatment
biospectrumasia
September 27, 2019
Building on its commitment to deliver the highest quality medicines to patients around the world, Thermo Fisher and Frontier Biotechnologies, Inc., a biopharmaceutical company based in China, announced a strategic partnership to accelerate the commerciali
-
Thermo Fisher Collaborates with Frontier Biotechnologies
biospectrumasia
September 26, 2019
Thermo Fisher Scientific Inc., the world leader in serving science, announced collaboration with China Frontier Biotechnologies Inc. to develop a novel treatment for human immunodeficiency virus (HIV).
-
Thermo Fisher expands clinical trials capabilities in China
biospectrumasia
September 26, 2019
To align with China's effort to encourage drug innovation, the newly expanded Suzhou facility will address the growing demand for drug development supply chain services and focus on high quality primary and secondary packaging solutions for customers and
-
KPMG, Thermo Fisher to work on gene interaction with medicines
biospectrumasia
August 28, 2019
Heightened capability aimed at improving pharmacy safety, health outcomes with the use of genetic testing